PHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Jun 2021
Amended Announcements
Please refer to the earlier announcement reference number: FRA-20082021-00001
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2021 |
| Quarter | 2 Qtr |
| Quarterly report for the financial period ended | 30 Jun 2021 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Jun 2021
|
30 Jun 2020
|
30 Jun 2021
|
30 Jun 2020
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
1,177,123
|
645,763
|
1,970,622
|
1,465,684
|
| 2 | Profit/(loss) before tax |
22,244
|
14,326
|
53,768
|
45,206
|
| 3 | Profit/(loss) for the period |
13,888
|
9,607
|
36,716
|
32,022
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
13,704
|
9,979
|
36,840
|
32,378
|
| 5 | Basic earnings/(loss) per share (Subunit) |
1.05
|
0.76
|
2.82
|
2.48
|
| 6 | Proposed/Declared dividend per share (Subunit) |
1.50
|
0.50
|
2.30
|
1.70
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.2730
|
0.2580
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 20 Aug 2021 |
| Category | Financial Results |
| Reference Number | FRA-20082021-00042 |